查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552489

甲霉菌病全球市场、规模、占有率、趋势、行业分析报告：依类型、治疗、地区 - 市场预测，2024-2032

Global Onychomycosis Market Size, Share, Trends, Industry Analysis Report: By Type, By Treatment (Topical, Oral and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Market Forecast, 2024 - 2032.
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球甲霉菌病市场规模预计将达到56.8946亿美元。本研究报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

由于人们对真菌疾病的认识不断提高以及公众意识的增强，甲真菌病市场显着成长。这使得人们能够及早发现并更了解甲霉菌病等真菌感染的影响。

2023年 9月，美国疾病管制与预防中心 (CDC) 认可了真菌疾病意识週 (FDAW) 。每年，疾病预防控制中心及其合作伙伴都会参与倡议和外展活动，以提高公众对真菌感染的认识。在2023年 FDAW 即将到来之际，各种事件凸显了真菌疾病日益严峻的挑战、复杂性和重大影响。

此外，雷射已获得美国食品药物管理局 (FDA) 的批准，技术的进步导致其用于治疗甲霉菌病，有助于市场的扩大。

根据Indian Dermatology Online Journal报导，局部治疗与点阵 CO2 雷射结合可以提高甲霉菌病治疗的效果。有几个因素会影响治疗结果，包括甲板厚度、甲霉菌病的程度和类型、疗程次数和同时治疗。点阵 CO2 雷射治疗透过在指甲上形成一个开口，在 42 天内将局部药物输送改善 3-4 倍。因此，使用点阵CO2雷射作为甲霉菌病局部治疗的预处理是有益的。

此外，与外用抗真菌药物相比，口服治疗甲真菌病的成功率更高、治疗时间更短，因此越来越受到患者的欢迎。这种真菌疾病的主要治疗方法是口服terbinafine hydrochloride。许多仿製药製造商推出口服药物来解决日益增多的甲霉菌病病例。

例如，2021 年 6 月，Glenmark Pharmaceuticals 的治疗等效和生物等效茶碱缓释片获得美国FDA批准，有450毫克和300毫克两种规格，用于治疗甲霉菌病。

甲霉菌病市场报告亮点

远端甲下甲霉菌病市场占据主导地位。这是由于对治疗甲霉菌病的更有效药物的需求不断成长，导致 FDA 批准的数量不断增加。

在预测期内，外用药物细分市场占据主导地位，因为外用药物的副作用较少。

在预测期内，由于目标疾病发生率的增加和政府政策的支持，北美地区主导了市场。

由于获得医疗服务的机会有限、卫生习惯不佳以及城市化进程加快，亚太地区预计将出现最快的年复合成长率。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球甲霉菌病市场洞察

  • 市场快照
  • 甲真菌病市场动态
    • 推动因素和机会
      • 对局部治疗的需求不断成长推动市场成长
      • 先进科技的崛起推动市场成长
    • 抑制因素和挑战
      • 存在替代疗法
  • PESTEL 分析
  • 甲真菌病市场的应用趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第5章 全球甲霉菌病市场：依类型

  • 主要调查结果
  • 简介
  • 远端甲下甲霉菌病
  • 近端甲下甲霉菌病

第6章 全球甲霉菌病市场：依治疗

  • 主要调查结果
  • 简介
  • 局部
  • 口头
  • 其他

第7章 全球甲霉菌病市场：依地区

  • 主要调查结果
  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 中东、非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东、非洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区

第8章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第9章 公司简介

  • Abbott
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Merck & Co., Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Lifesciences
Product Code: PM5011

The global onychomycosis market size is expected to reach USD 5,689.46 million by 2032, according to a new study by Polaris Market Research. The report "Global Onychomycosis Market Size, Share, Trends, Industry Analysis Report: By Type, By Treatment (Topical, Oral and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The onychomycosis market is experiencing significant growth due to increased recognition of fungal diseases and improved public awareness. This has led to early detection and better understanding of the effects of fungal infections, such as onychomycosis.

In September 2023, the Centers for Disease Control and Prevention (CDC) recognized Fungal Disease Awareness Week (FDAW). Every year, the CDC and its partners participate in initiatives and outreach efforts to raise public awareness of fungal infections. Leading up to FDAW in 2023, various events emphasized the growing challenges, complexities, and significant impacts of fungal diseases.

Furthermore, lasers have received approval from the Food and Drug Administration (FDA), and technological advancements have led to the use of lasers in the treatment of onychomycosis, contributing to the expansion of the market.

As per the Indian Dermatology Online Journal, combining topical therapy with fractional CO2 laser can enhance the effectiveness of onychomycosis treatment. Several factors, such as nail plate thickness, extent and type of onychomycosis, number of sessions, and concurrent therapy, can influence treatment results. Fractional CO2 laser treatment involves creating openings in the nail, which improves the delivery of topical drugs by three to four times over 42 days. Therefore, using fractional CO2 laser as a pre-treatment alongside topical therapy for onychomycosis can be beneficial.

Furthermore, oral treatment for onychomycosis is becoming increasingly popular among patients due to its higher success rates and shorter treatment durations compared to topical antifungals. The main treatment for this fungal infection is oral terbinafine hydrochloride. Many generic manufacturers are introducing oral treatments to address the growing prevalence of onychomycosis.

For instance, in June 2021, Glenmark Pharmaceuticals was granted approval by the U.S. FDA for their therapeutically equivalent and bioequivalent theophylline extended-release tablets, available in 450 mg and 300 mg for the treatment of onychomycosis.

Onychomycosis Market Report Highlights

The distal subungual onychomycosis segment dominated the market. This is due to the rising number of approvals by the FDA in response to the increasing demand for more effective medications for onychomycosis treatment.

The topical segment dominated the market over the forecast period as topical treatments are associated with fewer side effects.

The North America region dominated the market over the forecast period owing to the increased occurrence of the target disease and supportive government policies.

The Asia-Pacific region is expected to grow at the fastest CAGR owing to the limited access to healthcare services, poor hygiene practices, and extensive urbanization.

The global key market players include Bausch Health Companies Inc., Moberg Pharma AB, Abbott, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Merck & Co., Inc., Novartis AG, Zydus Lifesciences and Sun Pharmaceutical Industries Ltd.

Polaris Market Research has segmented the onychomycosis market report based on type, treatment, and region:

Onychomycosis, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Others

Onychomycosis, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Topical
  • Oral
  • Others

Onychomycosis, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Onychomycosis Market Insights

  • 4.1. Onychomycosis Market - Market Snapshot
  • 4.2. Onychomycosis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Topical Therapies is Driving the Market Growth
      • 4.2.1.2. Rising Advanced Technologies is Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Presence of Alternative Therapies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Onychomycosis Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Onychomycosis Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • 5.3. Distal Subungual Onychomycosis
    • 5.3.1. Global Onychomycosis Market, by Distal Subungual Onychomycosis, by Region, 2019-2032 (USD Million)
  • 5.4. Proximal Subungual Onychomycosis
    • 5.4.1. Global Onychomycosis Market, by Proximal Subungual Onychomycosis, by Region, 2019-2032 (USD Million)
    • 5.4.2. White Superficial Onychomycosis
      • 5.4.2.1. Global Onychomycosis Market, by White Superficial Onychomycosis, by Region, 2019-2032 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Global Onychomycosis Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Onychomycosis Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 6.3. Topical
    • 6.3.1. Global Onychomycosis Market, by Topical, by Region, 2019-2032 (USD Million)
  • 6.4. Oral
    • 6.4.1. Global Onychomycosis Market, by Oral, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Onychomycosis Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Onychomycosis Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Onychomycosis Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Onychomycosis Market - North America
    • 7.3.1. North America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.3.2. North America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.3.3. Onychomycosis Market - U.S.
      • 7.3.3.1. U.S.: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.3.4. Onychomycosis Market - Canada
      • 7.3.4.1. Canada: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.4. Onychomycosis Market - Europe
    • 7.4.1. Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.4.2. Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.3. Onychomycosis Market - UK
      • 7.4.3.1. UK: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.4. Onychomycosis Market - France
      • 7.4.4.1. France: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.4.2. France: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.5. Onychomycosis Market - Germany
      • 7.4.5.1. Germany: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.6. Onychomycosis Market - Italy
      • 7.4.6.1. Italy: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.7. Onychomycosis Market - Spain
      • 7.4.7.1. Spain: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.8. Onychomycosis Market - Netherlands
      • 7.4.8.1. Netherlands: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.9. Onychomycosis Market - Russia
      • 7.4.9.1. Russia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.4.10. Onychomycosis Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.4.10.2. Rest of Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.5. Onychomycosis Market - Asia Pacific
    • 7.5.1. Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.3. Onychomycosis Market - China
      • 7.5.3.1. China: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.3.2. China: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.4. Onychomycosis Market - India
      • 7.5.4.1. India: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.4.2. India: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.5. Onychomycosis Market - Malaysia
      • 7.5.5.1. Malaysia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.6. Onychomycosis Market - Japan
      • 7.5.6.1. Japan: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.7. Onychomycosis Market - Indonesia
      • 7.5.7.1. Indonesia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.8. Onychomycosis Market - South Korea
      • 7.5.8.1. South Korea: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.9. Onychomycosis Market - Australia
      • 7.5.9.1. Australia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.9.2. Australia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.5.10. Onychomycosis Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.6. Onychomycosis Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.3. Onychomycosis Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.4. Onychomycosis Market - UAE
      • 7.6.4.1. UAE: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.5. Onychomycosis Market - Israel
      • 7.6.5.1. Israel: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.6. Onychomycosis Market - South Africa
      • 7.6.6.1. South Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.6.7. Onychomycosis Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • 7.7. Onychomycosis Market - Latin America
    • 7.7.1. Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.3. Onychomycosis Market - Mexico
      • 7.7.3.1. Mexico: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.4. Onychomycosis Market - Brazil
      • 7.7.4.1. Brazil: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.5. Onychomycosis Market - Argentina
      • 7.7.5.1. Argentina: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
    • 7.7.6. Onychomycosis Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
      • 7.7.6.2. Rest of Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bausch Health Companies Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cipla Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Merck & Co., Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Moberg Pharma AB
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Novartis AG
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Pfizer Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Sun Pharmaceutical Industries Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Teva Pharmaceutical Industries Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Zydus Lifesciences
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

  • Table 1 Global Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 3 North America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 4 North America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 5 U.S.: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 7 Canada: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 8 Canada: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 9 Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 10 Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 11 UK: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 12 UK: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 13 France: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 14 France: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 15 Germany: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 16 Germany: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 17 Italy: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 18 Italy: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 19 Spain: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 20 Spain: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 21 Netherlands: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 23 Russia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 24 Russia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 25 Rest of Europe: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 26 Rest of Europe: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 28 Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 29 China: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 30 China: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 31 India: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 32 India: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 33 Malaysia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 34 Malaysia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 35 Japan: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 36 Japan: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 37 Indonesia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 38 Indonesia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 39 South Korea: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 40 South Korea: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 41 Australia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 42 Australia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 43 Vietnam: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 44 Vietnam: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 45 Rest of Asia Pacific: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 46 Rest of Asia Pacific: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 47 Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 48 Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 49 Saudi Arabia: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 50 Saudi Arabia: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 51 UAE: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 52 UAE: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 53 Israel: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 54 Israel: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 55 South Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 56 South Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 57 Rest of Middle East & Africa: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 58 Rest of Middle East & Africa: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 59 Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 60 Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 61 Mexico: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 62 Mexico: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 63 Brazil: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 64 Brazil: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 65 Argentina: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 66 Argentina: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)
  • Table 67 Rest of Latin America: Onychomycosis Market, by Type, 2019-2032 (USD Million)
  • Table 68 Rest of Latin America: Onychomycosis Market, by Treatment, 2019-2032 (USD Million)

List of Figures:

  • Figure 1. Global Onychomycosis Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Onychomycosis Market, by Type, 2023 & 2032 (USD Million)
  • Figure 8. Market by Treatment
  • Figure 9. Global Onychomycosis Market, by Treatment, 2023 & 2032 (USD Million)
  • Figure 10. Onychomycosis Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11. Figure 13. Strategic Analysis - Onychomycosis Market